equisetum arvense sp
Botanicalexperimental
Clinical trial activity
3 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Aug 1, 2013 (NCT02297360)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- equisetum arvense sp
- equisetum arvense stem
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04338477 | Phase 3 | Feb 12, 2018 | Bioforce AG |
| NCT02297360 | N/A | Aug 1, 2013 | Ablon Skin Institute Research Center, Irish Response t/a Lifes2good |
| NCT02396160 | N/A | Aug 1, 2013 | Endeavour College of Natural Health, Seipel Group Pty Ltd, University of Queensland, University of Tasmania |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ablon Skin Institute Research Center | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Bioforce AG | For profit | 1 | 1 | 1 | 2018 |
| Endeavour College of Natural Health | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Irish Response t/a Lifes2good | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Seipel Group Pty Ltd | For profit | 1 | 0 | 1 | 2013 |
| University of Queensland | Academic/Hospital | 1 | 1 | 1 | 2013 |
| University of Tasmania | Academic/Hospital | 1 | 0 | 1 | 2013 |
7 organizations
Page 1 / 1